NeoMedLight
French medical device company that develops phototherapy devices using proprietary Lightex® woven optic fiber technology for cancer supportive care (CareMin650) and neonatal jaundice treatment (BiliCocoon), selling to hospitals and cancer centers across 30 countries via direct sales and distributors.
- Company typePrivate
- Founded2014
- HeadquartersVilleurbanne, France
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What NeoMedLight does
NeoMedLight is a French medical device company founded in February 2014 as a spin-off of Brochier Technologies, headquartered in Villeurbanne (Lyon metropolitan area), and operating with 1-10 employees. The company commercializes phototherapy devices built on Lightex®, a patented technology platform that enables light emission through woven optic fibers, allowing therapeutic light to be delivered via flexible textile substrates rather than rigid laser or LED panels. Its portfolio consists of two products: CareMin650™, a 650 nm red-LED photobiomodulation system CE-marked in March 2020 for the prevention and treatment of chemotherapy/radiotherapy-induced mucositis and dermatitis, configured with oral pads (50 cm²) and derma pads (75 cm²) plus disposable protective sleeves; and BiliCocoon®, a neonatal phototherapy system (Bag System for term babies, Nest System for preterm) for treating hyperbilirubinemia at 430-490 nm without separating mother and newborn, available in approximately 30 countries.
NeoMedLight firmographics
Firmographics- Name
- NeoMedLight
- Legal name
- NEOMEDLIGHT
- Website
- https://neomedlight.com
- Company type
- Private
- Founded year
- 2014
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- French medical device company that develops phototherapy devices using proprietary Lightex® woven optic fiber technology for cancer supportive care (CareMin650) and neonatal jaundice treatment (BiliCocoon), selling to hospitals and cancer centers across 30 countries via direct sales and distributors.
- Ownership category
- akta.pro rank
NeoMedLight industry classification
Industry- Product category
- Medical Phototherapy Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro industry
- Laser & Energy-Based DermatologySkincare Devices & Beauty Tech (LED, Microcurrent, Cleansing Devices)
Keywords
Where NeoMedLight is headquartered
LocationHeadquarters
- HQ city
- Villeurbanne
- HQ country
- France
- HQ region
- Europe
Offices1 record
Markets served
NeoMedLight business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations
Revenue model
- Medical Device Sales (CareMin650): Sale of CareMin650 photobiomodulation system for cancer supportive care. Includes Lightbox unit, light pads (oral/derma), and disposable protective sleeves. Priced for hospital and cancer treatment center deployment.
- Medical Device Sales (BiliCocoon): Sale of BiliCocoon phototherapy system for neonatal jaundice treatment. Includes Lightbox, LED light pads, and bag/nest systems. Commercialized in 30 countries through distributor network.
- Disposable Consumables: Ongoing revenue from disposable protective sleeves for CareMin650 light pads, ensuring hygiene between patients and recurring purchase relationship.
- Professional Services and Training: Training and tutorial materials, user guides, and clinical support services for healthcare professionals using the devices.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Multi-year contract | CareMin650 system with oral and derma pads |
| One time/ perpetual license | Multi-year contract | BiliCocoon system (Bag or Nest) |
| Unit Pricing | Pay-as-you-go | Disposable sleeves for light pads |
Go-to-market motion3 records
Distribution channels4 records
Marketing channels7 records
NeoMedLight product offering
Product offeringCore offering
NeoMedLight develops and manufactures medical devices for phototherapy based on its proprietary Lightex® woven optic fiber technology. Its portfolio includes CareMin650™, a CE-marked red-LED photobiomodulation device for preventing and treating mucositis and dermatitis in cancer patients undergoing chemotherapy or radiotherapy, and BiliCocoon®, a flexible phototherapy system for treating neonatal jaundice without separating mother and baby. The devices are sold to hospitals and cancer treatment centers through a combination of direct sales and an international distributor network.
Product overview
NeoMedLight develops medical devices using proprietary Lightex technology—woven optic fibers that emit light—for phototherapy applications. The portfolio consists of two core products: CareMin650 (a CE-marked photobiomodulation device launched March 2020 for preventing and treating mucositis and dermatitis in cancer patients) and BiliCocoon (a neonatal jaundice phototherapy device with two systems: Nest for preterm babies and Bag for term babies). Both products leverage the same fundamental Lightex woven optic fiber technology platform but target different therapeutic applications.
Differentiator
Problem solved
Functional benefit
Brands
- BiliCocoon®: Phototherapy device for neonatal jaundice treatment. Certified ISO13485, offering intensive and homogeneous irradiance with large body surface coverage. Available in Bag and Nest systems.
- CareMin650™
- Lightex®
Products and services
- CareMin650™ A red-LED (650nm) photobiomodulation medical device for the prevention and treatment of mucositis and dermatitis in cancer patients undergoing chemotherapy or radiotherapy. The system comprises a Lightbox unit with touchscreen control, oral pads (50 cm² treatment surface) and derma pads (75 cm² treatment surface), plus disposable protective sleeves. CE-marked and sold to hospitals and cancer treatment centers.
- BiliCocoon® A phototherapy device for treating neonatal hyperbilirubinemia (jaundice) without separating mother and newborn. Features intensive homogeneous irradiance (35 µW/cm²/nm) with 1,200 cm² body surface coverage, emitting light in the 430-490nm bilirubin absorption spectrum. Available in two configurations: Nest (for preterm babies, incubator-compatible) and Bag (for term babies, providing 360° exposure). Commercialised in 30 countries through an international distributor network.
Quantifiable outcome
- Mucositis and dermatitis affect 40-80% of cancer patients depending on cancer type
- +5 more outcomes
Companies that use NeoMedLight
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles2 records
NeoMedLight technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
NeoMedLight partnerships and signals
Strategic signalPartnerships
23 partnerships are on record, tiered core, flagship and minor.
- PRHOINSAcoreExclusive distributor for BiliCocoon in Spain. Located at Avda. Jose Abascal 55, 28003 Madrid. Contact: [email protected]
- EUROCAREcoreDistributor for BiliCocoon in France. Located at 8 Rue Ernest Gouin, 78290 Coissy-sur-Seine. Contact: [email protected]
- International BiomedicalcoreDistributor for BiliCocoon in USA. Located at 8206 Cross Park Drive, Austin, Texas 78754. Contact: [email protected]
- Central Medical Supplies LtdcoreSole UK distributor for BiliCocoon since March 2017. Located at CMS House, Fynney Fields, Brooklands Way, Leek, Staffordshire, ST13 7QG. Contact: [email protected]
- REM SYSTEMS (Paragon Care)coreDistributor for BiliCocoon in Australia. Located at 3/12-24 Talavera Rd, Macquarie Park NSW 2113. Contact: [email protected]
- AdQuipment Medical B.V.coreDistributor for BiliCocoon in Netherlands. Located at Chr. Huygensweg 25, 3225 LD Hellevoetsluis. Contact: [email protected]
- KanmedcoreDistributor for BiliCocoon in Sweden. Located at Gårdsfogdevägen 18B, 168 67 Bromma. Contact: [email protected]
- EumedicscoreDistributor for BiliCocoon in Austria. Located at Scheringgasse 2, A-1140 Wien. Contact: [email protected]
- MeditsiinigruppcoreDistributor for BiliCocoon in Estonia. Located at Pärnu str 499, 76401 Laagri, Harjumaa. Contact: [email protected]
- MedCare VisionscoreDistributor for BiliCocoon in Germany. Located at Franz-Lehner-Straße 3, D-85716 Unterschleißheim. Contact: [email protected]
- J.B. CarecoreDistributor for BiliCocoon in Denmark. Located at Anelystparken 31B, 8381 Tilst. Contact: [email protected]
- INSPIRAcoreDistributor for BiliCocoon in Slovenia. Located at Pot na Labar 9, Ljubljana, 1000. Contact: [email protected]
- TEHNOMEDIKAcoreDistributor for BiliCocoon in Croatia. Located at Savska cesta 141, 10000 Zagreb. Contact: [email protected]
- Hessa Medical Equipments Company L.L.C.coreDistributor for BiliCocoon in UAE. Located at Al Habtoor warehouse 51, Industrial area 3, Al Qusais, Dubai. Contact: [email protected]
- Laboratoires CTRScorePartner for CareMin650 in France. Located at 63 rue de l'est, 92100 Boulogne Billancourt. Contact: [email protected]
- Innovative Technologie Völp e.U.corePartner for CareMin650 in Austria. Located at Exlgasse 20a, 6020 Innsbruck. Contact: [email protected]
- Oncology Imaging Systems LtdcorePartner for CareMin650 in UK. Located at The Paddock, Carriers Way, East Hoathly, East Sussex BN8 6AG. Contact: [email protected]
- DNSFCAREcorePartner for CareMin650 in Denmark. Located at Teglbaekvej 16, 8361 Hasselager. Contact: [email protected]
- Invest MedicalcorePartner for CareMin650 in Estonia. Located at Punane 56, Tallin, 13619. Contact: [email protected]
- PROHINSAcorePartner for CareMin650 in Spain. Located at Avda. Jose Abascal 55, 28003 Madrid. Contact: [email protected]
- ESTRO (European Society for Radiotherapy & Oncology)flagshipStrategic collaboration for webinars and education on photobiomodulation. Hosted joint webinar May 2020 on mucositis and dermatitis in cancer patients. Satellite symposium at ESTRO 2021.
- Brochier TechnologiescoreParent company from which NeoMedLight spun off. Provider of proprietary woven optic fiber technology and technical weaving expertise. NeoMedLight focuses on medical applications leveraging the patented flexible luminous fabric.
- RoseUp AssociationminorFrench breast cancer patient association featuring CareMin650 in Rose Magazine (February 2020). Association supports, informs, and defends rights of women affected by cancer.
Scale indicators6 records
Recent moves7 records
Expansion highlights5 records
NeoMedLight competitors and assessment
Company assessmentBroad incumbents
- Solta Medical: Established energy-based device manufacturer (Thermage, Fraxel, Clear+Brilliant) operating in dermatology and aesthetics. Indirect comparison point: broader energy-based dermatology portfolio where NeoMedLight's CareMin650 could be an oncology-supportive indication adjacent to existing energy-device procurement.
- Dräger: Large German medical technology company with a neonatal care portfolio including phototherapy devices such as BiliBlanket. Overlaps with NeoMedLight's BiliCocoon in NICU customers but is part of a much broader anesthesia, ventilation, and patient monitoring portfolio.
- Cynosure: US-based manufacturer of energy-based aesthetic and medical devices including light-based platforms. Provides a reference for how energy-based device companies commercialize through hospital/clinical channels but operates at a much broader portfolio and scale than NeoMedLight.
Direct peers
- Erchonia: US manufacturer of low-level laser therapy devices including PBM systems with FDA clearances for pain, inflammation, and dermatology. Competes in the same energy-based phototherapy category as CareMin650 with overlapping hospital/clinical channels.
- Natus Medical: US-listed medical device company with a dedicated neonatal care portfolio including phototherapy systems for hyperbilirubinemia. Direct BiliCocoon competitor in the neonatal jaundice market globally, with established hospital sales infrastructure.
- LiteCure: US PBM device company offering Class IV laser and LED phototherapy products for pain management, rehabilitation, and wound care. Direct comparison point for NeoMedLight's Lightex® technology in non-oncology PBM applications.
- Apira Science: US-based PBM device company (iRestore hair growth) developing light-based therapy platforms. Comparable in core LED PBM technology and regulatory approach though primarily in adjacent aesthetic indications.
- Biolux Research: Developer of OrthoPulse and other LED-based photobiomodulation devices with regulatory clearances across North America and EU. Comparable to NeoMedLight in modality, technology (LED PBM), and clinical use-case expansion strategy.
- Thor Photomedicine: UK-based manufacturer of LED-based photobiomodulation devices used in oncology supportive care (mucositis), wound healing, and musculoskeletal indications. Most directly comparable peer to NeoMedLight's CareMin650 in terms of modality (LED PBM), customer base (oncology centers, hospitals), and clinical positioning.
Regional players
- Atom Medical: Japanese medical device manufacturer specialized in neonatal care including phototherapy systems. Comparable to BiliCocoon's product class but primarily competes in APAC hospitals rather than the European channel NeoMedLight targets.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
NeoMedLight social profiles
Digital presenceNeoMedLight compliance and trust
Trust signalCompliance2 records
NeoMedLight financial estimates
Financial estimateRevenue estimate
Valuation estimate
NeoMedLight leadership team
Management profileNumber of profiles
Profiles2 records
NeoMedLight funding detail
Funding detailFunding overview
Funding rounds2 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
NeoMedLight M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about NeoMedLight
What does NeoMedLight do?
NeoMedLight develops and manufactures medical devices for phototherapy based on its proprietary Lightex® woven optic fiber technology. Its portfolio includes CareMin650™, a CE-marked red-LED photobiomodulation device for preventing and treating mucositis and dermatitis in cancer patients undergoing chemotherapy or radiotherapy, and BiliCocoon®, a flexible phototherapy system for treating neonatal jaundice without separating mother and baby. The devices are sold to hospitals and cancer treatment centers through a combination of direct sales and an international distributor network.
Is NeoMedLight a public or private company?
NeoMedLight is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was NeoMedLight founded?
NeoMedLight was founded in 2014. It employs 1 to 10 people.
Where is NeoMedLight based?
NeoMedLight is headquartered in Villeurbanne, France, in the Europe region.
How does NeoMedLight make money?
Four revenue lines are on record. Medical Device Sales (CareMin650) is the primary driver. The others are medical Device Sales (BiliCocoon), disposable Consumables and professional Services and Training.
Who are NeoMedLight's main competitors?
Broad incumbents on record are Solta Medical, Dräger and Cynosure. Direct peers are Erchonia, Natus Medical, LiteCure, Apira Science, Biolux Research and Thor Photomedicine. Atom Medical is listed as a regional player.
Does NeoMedLight have an API?
No public API is recorded for NeoMedLight.
What industry is NeoMedLight in?
NeoMedLight's product category is Medical Phototherapy Devices. Its primary akta.pro industry code is HLAKACAF, Laser & Energy-Based Dermatology, with a secondary code of CRABAAAJ, Skincare Devices & Beauty Tech (LED, Microcurrent, Cleansing Devices). Its NAICS code is 334510 and its SIC code is 3845.